AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24027184 — intervention group
Group type: EXPERIMENTAL
Intervention: Total n-6 PUFAs (including linoleic acid and arachidonic acid)
Number of subjects: 843
Study 21262345 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 39
Study 21262345 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 39
Study 18306849 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive treatment modalities
Number of subjects: 0
Study 18306849 — intervention group
Group type: COMPARATOR
Intervention: Surgical intervention
Number of subjects: 0
Study 16835528 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver alloy-coated Foley catheters
Number of subjects: 117
Study 16835528 — intervention group
Group type: COMPARATOR
Intervention: Standard catheters (pre-intervention)
Number of subjects: 117
Study 12892607 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser capsulotomy with 2 mm diameter
Number of subjects: 40
Study 12892607 — intervention group
Group type: COMPARATOR
Intervention: Laser capsulotomy with 4 mm diameter
Number of subjects: 40
Study 12892607 — intervention group
Group type: COMPARATOR
Intervention: Transparent posterior capsule group
Number of subjects: 40
Study 10975771 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose recombinant alpha-2a interferon (9 MU thrice weekly for 6 months, followed by 6 MU for another 6 months)
Number of subjects: 53
Study 10975771 — intervention group
Group type: COMPARATOR
Intervention: Low dose recombinant alpha-2a interferon (6 MU thrice weekly for 6 months, followed by 6 MU for another 6 months)
Number of subjects: 53
Study 10975771 — intervention group
Group type: EXPERIMENTAL
Intervention: One log viral load decrease at 2 or 4 weeks
Number of subjects: 53
Study 7847866 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% lidocaine gel applied locally to painful skin area
Number of subjects: 39
Study 7847866 — intervention group
Group type: COMPARATOR
Intervention: Remote application of lidocaine gel to mirror-image skin
Number of subjects: 39
Study 7847866 — intervention group
Group type: COMPARATOR
Intervention: Vehicle applied bilaterally (placebo)
Number of subjects: 39
Study 2128266 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard continuous total parenteral nutrition (S-TPN)
Number of subjects: 20
Study 2128266 — intervention group
Group type: COMPARATOR
Intervention: Cyclic total parenteral nutrition (C-TPN)
Number of subjects: 20
Study 7013403 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1,200 mg daily)
Number of subjects: 24
Study 7013403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31149873 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottom-vented canisters in horizontal position at high isoflurane flow rate
Number of subjects: 24
Study 31149873 — intervention group
Group type: EXPERIMENTAL
Intervention: Top-vented canisters in horizontal position at high isoflurane flow rate
Number of subjects: 24
Study 31149873 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical position of charcoal air-filtration canisters
Number of subjects: 24
Study 31149873 — intervention group
Group type: EXPERIMENTAL
Intervention: Canister elevation relative to the vaporizer
Number of subjects: 24
Study 31149873 — intervention group
Group type: EXPERIMENTAL
Intervention: Position of canisters (vertical vs horizontal)
Number of subjects: 24
Study 28121466 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-week trauma-sensitive yoga treatment
Number of subjects: 9
Study 25421015 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 54
Study 25421015 — intervention group
Group type: COMPARATOR
Intervention: Dapagliflozin 10 mg
Number of subjects: 54
Study 23464935 — intervention group
Group type: EXPERIMENTAL
Intervention: InterTan nail
Number of subjects: 132
Study 23464935 — intervention group
Group type: COMPARATOR
Intervention: PFNA‐II
Number of subjects: 132
Study 21255955 — intervention group
Group type: EXPERIMENTAL
Intervention: Wireless remote monitoring with automatic clinician alerts
Number of subjects: 1997
Study 21255955 — intervention group
Group type: COMPARATOR
Intervention: Standard in-office care
Number of subjects: 1997
Study 18956132 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (ALN, 70 mg/week) plus calcium (500 mg/daily) and vitamin D(3) (400 IU/daily)
Number of subjects: 239
Study 18956132 — intervention group
Group type: COMPARATOR
Intervention: Calcium (500 mg/daily) and vitamin D(3) (400 IU/daily; Ca-Vit D group)
Number of subjects: 239
Study 17050216 — intervention group
Group type: COMPARATOR
Intervention: Conventional dosing schedule (tablet phenytoin 100-400 mg/day OD or BD, tablet carbamazepine 200-800 mg BD, or both)
Number of subjects: 103
Study 17050216 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronotherapeutic dosing schedule (shift of daily dose to 20:00 h)
Number of subjects: 103
Study 14656363 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) Turbohaler 1600 mcg daily
Number of subjects: 40
Study 14656363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 10705771 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing different pictures at two assessments separated by 4 weeks
Number of subjects: 0
Study 10705771 — intervention group
Group type: COMPARATOR
Intervention: Viewing the same pictures at both assessments
Number of subjects: 0
Study 9137496 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg x 3
Number of subjects: 105
Study 9137496 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg x 3 + Methylprednisolone 4 mg
Number of subjects: 105
Study 9137496 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg x 3 + Methylprednisolone 4 mg + Ondansetron 8 mg x 3
Number of subjects: 105
Study 8121429 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed alarm system (experimental group, n = 35)
Number of subjects: 70
Study 8121429 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group, n = 35)
Number of subjects: 70
Study 8121429 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed alarm system (experimental group)
Number of subjects: 70
Study 2441175 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg acebutolol
Number of subjects: 6
Study 2441175 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg atenolol
Number of subjects: 6
Study 2441175 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg betaxolol
Number of subjects: 6
Study 2441175 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg metoprolol
Number of subjects: 6
Study 2441175 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg propranolol
Number of subjects: 6
Study 2441175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 29574866 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 29
Study 29574866 — intervention group
Group type: COMPARATOR
Intervention: No enamel matrix derivative (non-EMD)
Number of subjects: 29
Study 26705893 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 36
Study 26705893 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 36
Study 25907080 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 1861
Study 25907080 — intervention group
Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 1861
Study 23400742 — intervention group
Group type: EXPERIMENTAL
Intervention: etravirine 200 mg twice daily with fluconazole 200 mg daily
Number of subjects: 18
Study 23400742 — intervention group
Group type: EXPERIMENTAL
Intervention: etravirine 200 mg twice daily with voriconazole 200 mg twice daily
Number of subjects: 18
Study 23400742 — intervention group
Group type: COMPARATOR
Intervention: fluconazole alone
Number of subjects: 18
Study 23400742 — intervention group
Group type: COMPARATOR
Intervention: voriconazole alone
Number of subjects: 18
Study 20493604 — intervention group
Group type: EXPERIMENTAL
Intervention: Chairside computers
Number of subjects: 423
Study 20493604 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational videos
Number of subjects: 423
Study 20493604 — intervention group
Group type: EXPERIMENTAL
Intervention: Calling per diem staff
Number of subjects: 423
Study 20493604 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse competency examinations
Number of subjects: 423
Study 20493604 — intervention group
Group type: EXPERIMENTAL
Intervention: Technician cannulation mastery
Number of subjects: 423
Study 18758284 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment with open reduction and internal fixation using cannulated screw or Herbert screw.
Number of subjects: 12
Study 18758284 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed treatment with open reduction and internal fixation using cannulated screw or Herbert screw.
Number of subjects: 12
Study 18758284 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall clinical outcomes for all cases.
Number of subjects: 12
Study 16394298 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV vaccine (31,673 infants)
Number of subjects: 63225
Study 16394298 — intervention group
Group type: COMPARATOR
Intervention: Placebo (31,552 infants)
Number of subjects: 63225
Study 12868787 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioplegic leucocyte depletion (CLD)
Number of subjects: 40
Study 12868787 — intervention group
Group type: EXPERIMENTAL
Intervention: Total leucocyte depletion (TLD)
Number of subjects: 40
Study 12868787 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 12868787 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic leucocyte depletion (SLD)
Number of subjects: 40
Study 10977379 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Attack Survival Kit via home visit by EMT
Number of subjects: 1200
Study 10977379 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Attack Survival Kit via direct mail
Number of subjects: 1200
Study 10977379 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention group (EMT and direct mail)
Number of subjects: 1200
Study 10977379 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1200
Study 8852392 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone combined with digoxin
Number of subjects: 18
Study 8852392 — intervention group
Group type: COMPARATOR
Intervention: Digoxin alone
Number of subjects: 18
Study 8852392 — intervention group
Group type: COMPARATOR
Intervention: Nefazodone alone
Number of subjects: 18
Study 1503094 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐N1
Number of subjects: 20
Study 1503094 — intervention group
Group type: COMPARATOR
Intervention: Splenectomy
Number of subjects: 20
Study 6327926 — intervention group
Group type: EXPERIMENTAL
Intervention: Neocarzinostatin (NCZ)
Number of subjects: 61
Study 6327926 — intervention group
Group type: COMPARATOR
Intervention: m-AMSA
Number of subjects: 61
Study 6327926 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 61
Study 31552797 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic information with supportive communication
Number of subjects: 168
Study 31552797 — intervention group
Group type: COMPARATOR
Intervention: Behavioral information
Number of subjects: 168
Study 29621896 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional support seeking
Number of subjects: 744
Study 29621896 — intervention group
Group type: EXPERIMENTAL
Intervention: Felt stigma
Number of subjects: 744
Study 26626808 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall injuries
Number of subjects: 5148
Study 26626808 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall injuries among elderly (≥65 years)
Number of subjects: 5148
Study 26626808 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall injuries among children (<15 years)
Number of subjects: 5148
Study 26626808 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall injuries among adults (15-64 years)
Number of subjects: 5148
Study 26626808 — intervention group
Group type: EXPERIMENTAL
Intervention: Respondents spending significant time at home
Number of subjects: 5148
Study 26626808 — intervention group
Group type: EXPERIMENTAL
Intervention: Life-limiting disability due to fall injuries
Number of subjects: 5148
Study 26626808 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial hardship after fall injuries
Number of subjects: 5148
Study 25895196 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education about appropriate complementary feeding (CF) delivered through three education modules at baseline and two subsequent visits 10 weeks apart.
Number of subjects: 0
Study 25895196 — intervention group
Group type: COMPARATOR
Intervention: Control group received advice about breastfeeding (BF) according to national guidelines.
Number of subjects: 0
Study 23405792 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Xuanju Capsule plus vitamin E
Number of subjects: 50
Study 23405792 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E (Control)
Number of subjects: 50
Study 19579641 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 20 mg
Number of subjects: 12
Study 19579641 — intervention group
Group type: COMPARATOR
Intervention: lansoprazole 30 mg
Number of subjects: 12
Study 17502549 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (400 mg/day)
Number of subjects: 36
Study 17502549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 15170874 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (0.5 mg/kg/day for 3 days, 0.25 mg/kg/day for 3 days, 0.1 mg/kg/day on day 7; total dose 2.35 mg/kg)
Number of subjects: 62
Study 15170874 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone (0.2 mg/kg/day for 3 days and 0.1 mg/kg/day for 4 days; total dose 1 mg/kg)
Number of subjects: 62
Study 15170874 — intervention group
Group type: COMPARATOR
Intervention: Comparison between high-dose and low-dose dexamethasone
Number of subjects: 62
Study 15305783 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual screening for fecal occult blood
Number of subjects: 235000
Study 15305783 — intervention group
Group type: EXPERIMENTAL
Intervention: Biennial screening for fecal occult blood
Number of subjects: 235000
Study 15305783 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 235000
Study 9854132 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair
Number of subjects: 0
Study 9854132 — intervention group
Group type: COMPARATOR
Intervention: Open hernia repair
Number of subjects: 0
Study 8092087 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.5 mg methionine.kg‐1.d‐1 plus 0 mg cystine.kg‐1.d‐1
Number of subjects: 8
Study 8092087 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.5 mg methionine.kg‐1.d‐1 plus 5.2 mg cystine.kg‐1.d‐1
Number of subjects: 8
Study 8092087 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.5 mg methionine.kg‐1.d‐1 plus 10.5 mg cystine.kg‐1.d‐1
Number of subjects: 8
Study 8092087 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.5 mg methionine.kg‐1.d‐1 plus 20.9 mg cystine.kg‐1.d‐1
Number of subjects: 8
Study 8092087 — intervention group
Group type: COMPARATOR
Intervention: 13 mg methionine.kg‐1.d‐1 without cystine
Number of subjects: 8
Study 2643866 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 36
Study 2643866 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 36
Study 2643866 — intervention group
Group type: EXPERIMENTAL
Intervention: Both agents
Number of subjects: 36
Study 31880338 — intervention group
Group type: EXPERIMENTAL
Intervention: MDTP + NMES
Number of subjects: 53
Study 31880338 — intervention group
Group type: EXPERIMENTAL
Intervention: MDTP
Number of subjects: 53
Study 31880338 — intervention group
Group type: COMPARATOR
Intervention: MDTP + sham NMES
Number of subjects: 53
Study 31880338 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) swallowing therapy
Number of subjects: 53
Study 30565191 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval walking training (IWT)
Number of subjects: 68
Study 30565191 — intervention group
Group type: COMPARATOR
Intervention: Normal walking training (NWT)
Number of subjects: 68
Study 28561762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy yogurt containing Lactobacillus paracasei ssp. paracasei, Bifidobacterium animalis ssp. lactis and heat-treated Lactobacillus plantarum
Number of subjects: 200
Study 28561762 — intervention group
Group type: COMPARATOR
Intervention: Placebo (milk)
Number of subjects: 200
Study 25167796 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear array EUS training after radial-scanning EUS training (Group A)
Number of subjects: 18
Study 25167796 — intervention group
Group type: COMPARATOR
Intervention: Linear array EUS training alone (Group B)
Number of subjects: 18
Study 23819675 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with sparse verbs
Number of subjects: 6
Study 23819675 — intervention group
Group type: COMPARATOR
Intervention: Treatment with dense verbs
Number of subjects: 6
Study 21365055 — intervention group
Group type: EXPERIMENTAL
Intervention: ITI (Institut Straumann) implants
Number of subjects: 36
Study 21365055 — intervention group
Group type: EXPERIMENTAL
Intervention: SwissPlus (Zimmer Dental) implants
Number of subjects: 36
Study 21365055 — intervention group
Group type: EXPERIMENTAL
Intervention: Astra (Astra Tech) implants
Number of subjects: 36
Study 21365055 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 36
Study 19801020 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 30,000 IU intravenously before tenecteplase treatment
Number of subjects: 236
Study 19801020 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 236
Study 17114905 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided laser photocoagulation (PLP)
Number of subjects: 26
Study 17114905 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 26
Study 14748786 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid pre-screen
Number of subjects: 75355
Study 14748786 — intervention group
Group type: COMPARATOR
Intervention: No pre-screen
Number of subjects: 75355
Study 14748786 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine laboratory practice with rapid pre-screen
Number of subjects: 75355
Study 11491426 — intervention group
Group type: EXPERIMENTAL
Intervention: Donjoy custom‐fit ACL brace (CE 2000)
Number of subjects: 5
Study 11491426 — intervention group
Group type: COMPARATOR
Intervention: Donjoy off‐the‐shelf brace (Goldpoint)
Number of subjects: 5
Study 11491426 — intervention group
Group type: COMPARATOR
Intervention: Athletic taping technique
Number of subjects: 5
Study 9413414 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50‐200 mg daily)
Number of subjects: 0
Study 9413414 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (50‐150 mg daily)
Number of subjects: 0
Study 9413414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8501272 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer/fluoride dentifrice
Number of subjects: 120
Study 8501272 — intervention group
Group type: COMPARATOR
Intervention: Traditional fluoride containing dentifrice
Number of subjects: 120
Study 3781184 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (5 mg) intravenously 15 min before meal
Number of subjects: 9
Study 3781184 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (10 mg) intravenously 15 min before meal
Number of subjects: 9
Study 3781184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 29660018 — intervention group
Group type: EXPERIMENTAL
Intervention: IDES cases (n = 159)
Number of subjects: 322
Study 29660018 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 163)
Number of subjects: 322
Study 27118539 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT group: length of ATB guided by institutional protocol plus PCT dynamics
Number of subjects: 62
Study 27118539 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT group
Number of subjects: 62
Study 25495315 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypill strategy
Number of subjects: 0
Study 25495315 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 22008208 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% O(2)
Number of subjects: 35
Study 22008208 — intervention group
Group type: COMPARATOR
Intervention: CA
Number of subjects: 35
Study 20156348 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed therapy using FloTrac/Vigileo device (GDT-group, n = 30)
Number of subjects: 60
Study 20156348 — intervention group
Group type: COMPARATOR
Intervention: Standard management protocol (Control-group, n = 30)
Number of subjects: 60
Study 18576310 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based Arthritis Self-Management Program (ASMP)
Number of subjects: 855
Study 18576310 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 855
Study 16260965 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity PRMST (>=80% 1RM)
Number of subjects: 71
Study 16260965 — intervention group
Group type: COMPARATOR
Intervention: Low-resistance exercise (20% of the 1RM)
Number of subjects: 71
Study 16260965 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (100 mg of testosterone enanthate)
Number of subjects: 71
Study 16260965 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 16260965 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity PRMST
Number of subjects: 71
Study 16260965 — intervention group
Group type: COMPARATOR
Intervention: Low-resistance exercise
Number of subjects: 71
Study 11877261 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anti-D
Number of subjects: 28
Study 10096265 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg oral modafinil in the morning and 100 mg at midday
Number of subjects: 26
Study 10096265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 7781199 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 0.6 mg/kg IV as Solu‐Medrol
Number of subjects: 6
Study 7781199 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 6
Study 2228544 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 160